Endothelial Modulation for Angiogenic Therapy

Clinical trial NCT00134433 · COMPLETED

Trial details

NCT number: NCT00134433
Sponsor: Ottawa Heart Institute Research Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2004-11-01
Primary completion: 2007-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.